scholarly article | Q13442814 |
P2093 | author name string | Glinsky GV | |
Deutscher SL | |||
Quinn TP | |||
Huflejt ME | |||
Rittenhouse-Olson K | |||
Glinsky VV | |||
Glinskii OV | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
prostate cancer | Q181257 | ||
P304 | page(s) | 4851-4857 | |
P577 | publication date | 2001-06-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium | |
P478 | volume | 61 |
Q35066670 | A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties |
Q37328722 | A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction |
Q37302910 | ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis |
Q36950893 | Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients |
Q35201294 | Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche |
Q46678523 | Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium |
Q37581540 | Altered tumor-cell glycosylation promotes metastasis |
Q84075613 | Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3 |
Q40279445 | Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging |
Q24658379 | Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier |
Q38314353 | Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody |
Q36298206 | Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle |
Q35993085 | CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes |
Q35525289 | Cancer vaccines and carbohydrate epitopes |
Q47134233 | Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype |
Q28255527 | Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface |
Q24597542 | Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis |
Q31142810 | Combinatorial evolution of high-affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen |
Q40292897 | Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis |
Q60367969 | Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endothelium |
Q61903522 | Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity |
Q36200540 | Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines |
Q33489506 | Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen |
Q92812834 | Does Direct and Indirect Exposure to Ionising Radiation Influence the Metastatic Potential of Breast Cancer Cells |
Q31047849 | Effective combinatorial strategy to increase affinity of carbohydrate binding by peptides |
Q33576873 | Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane |
Q90397869 | Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate |
Q35892475 | Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding |
Q40606989 | Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells |
Q28255822 | Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas |
Q34522377 | Expression of antigen tf and galectin-3 in fibroadenoma |
Q38225141 | Extracellular galectin-3 in tumor progression and metastasis. |
Q42012840 | Extravasation of leukocytes in comparison to tumor cells. |
Q33935217 | Far beyond the usual biomarkers in breast cancer: a review |
Q36741513 | Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens |
Q35646658 | Galectin-3 and metastasis |
Q36326176 | Galectin-3 as a Potential Target to Prevent Cancer Metastasis. |
Q35945071 | Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. |
Q34626339 | Galectin-3: a potential target for cancer prevention. |
Q38160862 | Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers |
Q42288169 | Glycoamino Acid Analogues of the Thomsen-Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides |
Q27008374 | Glycoconjugates and related molecules in human vascular endothelial cells |
Q92724165 | Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis |
Q38757500 | Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability |
Q41478234 | Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis |
Q93186392 | Immunological Regulation of Vascular Inflammation During Cancer Metastasis |
Q36339643 | Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer |
Q34208137 | Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential |
Q34360666 | Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide |
Q35763903 | Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. |
Q35249810 | Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11 |
Q39690197 | Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. |
Q26749378 | Interaction of the Oncofetal Thomsen-Friedenreich Antigen with Galectins in Cancer Progression and Metastasis |
Q35646606 | Introduction to galectins |
Q38024987 | Isolated, disseminated and circulating tumour cells in prostate cancer |
Q36002985 | MUC1 is involved in trophoblast transendothelial migration |
Q34768486 | Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs |
Q24651188 | Modified citrus pectin anti-metastatic properties: one bullet, multiple targets |
Q98465934 | Molecular mechanisms and clinical management of cancer bone metastasis |
Q34536725 | Mucin-interacting proteins: from function to therapeutics |
Q24561606 | NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin |
Q34500864 | Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. |
Q36776494 | Onco-Golgi: Is Fragmentation a Gate to Cancer Progression? |
Q27014902 | Organelle targeting: third level of drug targeting |
Q49901112 | Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1. |
Q33532734 | Phage display in molecular imaging and diagnosis of cancer |
Q38359737 | Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3. |
Q37316672 | Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients |
Q52686871 | Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. |
Q91844287 | Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential |
Q33770947 | Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis |
Q43164816 | Regulation of tumor progression by extracellular galectin-3. |
Q35160084 | Sialyltransferases in cancer |
Q38366325 | Simple sugars to complex disease--mucin-type O-glycans in cancer |
Q36956344 | Stepping out of the flow: capillary extravasation in cancer metastasis |
Q35162645 | Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles |
Q37642032 | Synthesis of the tumor associative α-aminooxy disaccharide of the TF antigen and its conjugation to a polysaccharide immune stimulant. |
Q37328110 | Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo. |
Q98771478 | Targeting Galectins With Glycomimetics |
Q58712952 | Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy |
Q37333778 | The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship |
Q34622638 | The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression |
Q21093318 | The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis |
Q28261890 | The roles of Galectin-3 in autoimmunity and tumor progression |
Q26744538 | Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer |
Q36853557 | Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles |
Search more.